Concerns over the consequences of regional disparities for elderly French type 2 diabetes patients in the Gerodiab study

Floch, J.-P. Le; Fagot-Campagna, A.; Lassmann-Vague, V.; Tessier, Daniel; Vischer, Ulrich M.; Affres, Hélène; Alix, M; Archambeaud, F.; Barrou, Zina; Bauduceau, B.; Beau, P; Beltrán, Sourik; Benoit, Christine; Beressi, J-P; Bernachon, F; Berne, Christian; Berrut, Gilles; Blaimont, Aude; Blicklé, J. F.; Boda-Buccino, M.; Bohatier, Jérôme; Böhme, Philip; Bordier, L.; Bouchou, K; Bouillet, Benjamin; Bouilloud, F.; Bouix, R; Boulanger, Éric; Bourdel‐Marchasson, Isabelle; Bourgon, C.; Bourrinet, E; Brocker, P.; Bruckert, Isabelle; Capet, C.; Carette, Claire; Cariou, Bertrand; Carreau, Anne‐Marie; Vaurie, Charles.; Chamouni, S; Ciangura, C.; Collet-Gaudillat, C.; Combes-Moukhovsky, M-E; Constans, T.; Cordonnier, M.; Cuperlier, A.; Dambre, D; D'Avigneau, J; Botton, P De; Degros, V.; Delamarre-Damier, Florence; Denat, S; Desbiez, F.; Deumier, B; Dorey, Fred; Doucet, J.; Dresco, E.; Drutel, A.; Germain, E.; Dubois‐Laforgue, Danièle; Duly-Bouhanick, B.; Dupuy, O.; Dusselier, L.; Faucher-Kareche, S; Fendri, S.; Fontaine, P; Galinat, S.; Gentric, A.; Gin, H.; Glaise, F; Godeau, T; Gonzales, B.; Got, I.; Guerci, Bruno; Pj, Guillausseau; Hadjadj, Samy; Hadjali, Y; Halbron, M.; Halimi, Serge; Halter, C.; Hanaire, H.; Hardy, Victoria Ponce; Hartemann–Heurtier, Agnès; Haulot, J-P; Hequet, Fanny; Issa-Sayegh, M; Jan, P; Jeandidier, N.; Joseph-Henri, H; Julier, Ingrid; Kaloustian, E; Kerlan, V.; Kharitonnoff, T.; Ladsous, M.; Lahaxe, L.; Lamaraud, M-P; Lassenne, E; Lecerf, J. M.; Lecomte, P.; Leroux, I.; Lesven, S.; Lévy, Marc; Lopez, S.; Makiza, F; Manckoundia, Patrick; Pomeau, C Marquis; Mayaudon, H.; Micheli, Serena; Mira, R; Monnier, F; Mosnier-Pudar, Helen; Neri, Natividad; Normand, I; Pocard, Marc; Pagu, C; Pâris, Dominique; Penfornis, A.; Perie, J-L; Petit, J.-M.; Petit-Aubert, Gwenaelle; Pichot-Duclos, B; Pivois, L; Popelier, M.; Poulingue, G; Priner, M.; Quipourt, Valérie; Rasamisoa, M; Jl, Richard; Rigalleau, Vincent; Roudat, N; Sanz, C.; Jm, Serot; Sifi, D; Sirvain, S.; Slimani, Alisson; Sonnet, E.; Sosset, C; Soualah, A; Stroea, A; Tauveron, Igor; Timsit, José; Tschudnowsky, M.; Vambergue, A.; Vérier-Mine, O.; Verny, Christiane; Virally, Marie

doi:10.1016/j.diabet.2013.09.010

Cited by 4 publications

(2 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The consolidation of the results and the inferential analysis of the Brazilian research data were based on the findings of the GERODIAB cohort study carried out in Rouen, France. The GERODIAB cohort study is a French multicenter and prospective study designed to analyze the influence of glyce-mic control on morbidity-mortality in 987 patients with type 2 diabetes aged 70 years and older [9].…”

Section: Methodsmentioning

confidence: 99%

Clinical and epidemiological differences in diabetes: A cross-sectional study of the Brazilian population compared with the French GERODIAB cohort

Bezerra

Saintrain

Lima

et al. 2020

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

Section: Methodsmentioning

confidence: 99%

Clinical and epidemiological differences in diabetes: A cross-sectional study of the Brazilian population compared with the French GERODIAB cohort

Bezerra

Saintrain

Lima

et al. 2020

Diabetes Research and Clinical Practice

View full text Add to dashboard Cite

“…It is therefore difficult to know whether their medication treatment follows the recommendations and whether it is suitable to their clinical situation. The GERODIAB study is the first French, multicentre, prospective, observational, 5‐year follow‐up study designed to analyse the relation between glycaemic control and morbidity–mortality in type 2 diabetic patients aged 70 years and older . We report here on the results of their diabetic and geriatric situations at the study inclusion according to the treatment used.…”

Section: Introductionmentioning

confidence: 99%

Medical treatments of elderly, French patients with type 2 diabetes: results at inclusion in the GERODIAB Cohort

Doucet

Bauduceau

Floch³

et al. 2015

Fundamemntal Clinical Pharma

View full text Add to dashboard Cite

Prevalence of diabetes in the elderly increases, and half of the French diabetics are over the age of 75 years. The GERODIAB study is the first French multicentre, prospective, observational study designed to analyse over 5 years the influence of glycaemic control on morbidity-mortality in type 2 diabetics patients 70 years old and over. This study analysed the diabetic and geriatric factors associated with the treatment modalities, particularly insulin, at inclusion in the cohort. The cohort of 987 type 2 diabetics was divided into three groups according to the method of treatment. Slightly fewer than one-third of these patients (26.4%) were treated with insulin alone, 31% received insulin and oral antidiabetic drugs, and 42.7% oral antidiabetic drugs alone. The patients that received insulin alone were significantly older, had poorer glycaemic control (HbA1c = 7.9 ± 1.4, 7.8 ± 1.0 and 7.1 ± 1.2%, respectively; P < 0.001) and had greater alterations of glomerular filtration rate (GFR). HbA1c was below 6.5% in 15% of patients and 37.3% of patients had a GFR below 60 mL/min. The patients treated with insulin alone had significantly more hypoglycaemic episodes (respectively 53.3, 36.3 and 19.5%, P < 0.001), retinopathy, cardiovascular involvement and more specific geriatric complications, such as cognitive disorders (respectively 34.1, 31.4 and 23.6%, P = 0.006). In this specific population of elderly type 2 diabetic patients, diabetic and geriatric conditions significantly differed between the types of drug treatments. Considering low values of HbA1c and GFR, some patients seemed overtreated and other patients received inappropriate drugs.

show abstract

Étude des liens entre diabète de type 2 et critères gériatriques

Zulfiqar¹,

Dembele²,

Amadou³

et al. 2023

Soins Gérontologie

View full text Add to dashboard Cite

Concerns over the consequences of regional disparities for elderly French type 2 diabetes patients in the Gerodiab study

Cited by 4 publications

References 1 publication

Clinical and epidemiological differences in diabetes: A cross-sectional study of the Brazilian population compared with the French GERODIAB cohort

Clinical and epidemiological differences in diabetes: A cross-sectional study of the Brazilian population compared with the French GERODIAB cohort

Medical treatments of elderly, French patients with type 2 diabetes: results at inclusion in the GERODIAB Cohort

Étude des liens entre diabète de type 2 et critères gériatriques

Contact Info

Product

Resources

About